Normal view MARC view ISBD view

Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study.

Qureshi, Adnan I

Intra-arterial reteplase and intravenous abciximab in patients with acute ischemic stroke: an open-label, dose-ranging, phase I study. [electronic resource] - Neurosurgery Oct 2006 - 789-96; discussion 796-7 p. digital

Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

ISSN: 1524-4040

Standard No.: 10.1227/01.NEU.0000232862.06246.3D doi

Subjects--Topical Terms:
Abciximab
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal--administration & dosage
Arterial Occlusive Diseases--complications
Brain Ischemia--complications
Carotid Arteries
Cerebral Angiography
Cerebral Hemorrhage--chemically induced
Female
Fibrinolytic Agents--administration & dosage
Humans
Immunoglobulin Fab Fragments--administration & dosage
Injections, Intra-Arterial
Injections, Intravenous
Male
Middle Aged
Platelet Aggregation Inhibitors--administration & dosage
Platelet Glycoprotein GPIIb-IIIa Complex--antagonists & inhibitors
Recombinant Proteins--administration & dosage
Stroke--drug therapy
Tissue Plasminogen Activator--administration & dosage